常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.70/-1.26
|
|
企业价值
111.31M
|
| 资产负债 |
|
每股账面净值
2.67
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
53.48M
|
|
每股收益
3.87
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. |

2.6 
